The rise of genome sequencing has opened a new frontier for the issue that could drive divergence of the cancer care received by different races.
Researchers have published the first analysis of the 60,000 people sequenced through the Exome Aggregation Consortium.
The Pfizer study that identified 15 genome sites linked to depression in 23andMe’s database has sparked a surge in demands to access the repository.
Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.
Google's Art Levinson-helmed biotech Calico has hired Daphne Koller to build and lead its computational biology and machine learning team.
Synthego has emerged from stealth mode equipped with guide RNA products for use in CRISPR/Cas9 genome engineering.
Researchers at MIT have developed a framework to ensure genetic data can be shared freely without putting individuals’ privacy at risk.
Illumina has tasked FlowJo with developing data analysis software to support its expansion into high-throughput sequencing of single cells.
Stanford Medicine has picked Google Genomics to power its healthcare data science drive.
The team that founded Firecrest Clinical and led it to a takeout by CRO Icon has raised $6 million for its next startup, teckro.